Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Licenses Max Planck Tech for Photon Detection

NEW YORK (GenomeWeb News) – PerkinElmer has licensed photon detection technology developed by the Max Planck Institute for use in a range of molecular imaging applications, the Waltham, Mass.-based company said today.

Under the exclusive agreement with Max Planck Innovation, the Max Planck Institute's technology transfer arm, the company has licensed solid state silicon photomultiplier, or SiPM, technology that it will use in clinical diagnostics, as well as molecular detection and analytical applications, the company said.

The SiPM technology, which was developed by scientists at the Max Planck Institute for Physics and the Moscow State Engineering Physics Institute, offers high photon detection efficiencies, short response time, and low power consumption, which makes it useful in a range of low light level applications, the company said.

PerkinElmer's VP and GM of global detection, Michael Ersoni, said in a statement that the new technology "shows promise for several important human and environmental health applications."

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.